Publications by authors named "Long Runxiang"

Claim this Profile
E
Evaluation of Binding and Neutralizing Antibodies for Inactivated SARS-CoV-2 Vaccine Immunization.
Heng Zhao, Guorun Jiang, Cong Li, Yanchun Che, Runxiang Long

Diseases· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.
Tianhong Xie, Shuaiyao Lu, Zhanlong He, Hongqi Liu, Junbin Wang, Runxiang Long

Signal Transduct Target Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults.
Yanchun Che, Xiaoqiang Liu, Yi Pu, Meijian Zhou, Zhimei Zhao, Runxiang Long

Clin Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques.
Hongbo Chen, Zhongping Xie, Runxiang Long, Shengtao Fan, Heng Li

Mol Ther Methods Clin Dev· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.
Dandan Li, Ning Luan, Jing Li, Heng Zhao, Ying Zhang, Runxiang Long

Emerg Microbes Infect· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
Ting Yang, Baofeng Liu, Lei Yue, Tianhong Xie, Hua Li, Runxiang Long

Vaccine· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Runxiang Long

Vaccine· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
Lei Yue, Han Cao, Tianhong Xie, Runxiang Long, Hua Li

J Med Virol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses of a CV-A16 live attenuated candidate strain and its protective effects in rhesus monkeys.
Ting Yang, Tianhong Xie, Hua Li, Xia Song, Lei Yue, Runxiang Long

Emerg Microbes Infect· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys.
Ting Yang, Tianhong Xie, Xia Song, Dong Shen, Hua Li, Runxiang Long

Hum Vaccin Immunother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro.
Ting Yang, Hua Li, Lei Yue, Xia Song, Tianhong Xie, Runxiang Long

Virol J· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological characteristics of different epidemic enterovirus 71 strains and their pathogeneses in neonatal mice and rhesus monkeys.
Xie Zhongping, Li Hua, Yang Ting, Liu Zhengling, Feng Min, Long Runxiang

Virus Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis